Among T-cell malignancies, the clinical course of BIA-ALCL is, in most cases, indolent, similar to primary cutaneous ALCL (pcALCL); both lymphomas consistently express CD30, similar to systemic ALCL (sALCL) [14,43]. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.